Related Experiment Video
Updated: May 14, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Oncogenic Ras suppresses Cdk1 in a complex manner during the incubation of activated Xenopus egg extracts
Tun-Lan Huang1, Jerry P Pian, Bin-Tao Pan
1Graduate Center for Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Abstract:
The activity of Cdk1 is the driving force for entry into M-phase during the cell cycle. Activation of Cdk1 requires synthesis and accumulation of cyclin B, binding of cyclin B to Cdk1, and removal of the inhibitory tyr-15-Cdk1 phosphorylation. It was previously shown that oncogenic Ras suppresses Cdk1 activation during the incubation of activated Xenopus egg extracts. However, how oncogenic Ras suppresses Cdk1 remained unclear. Using the histone H1 kinase assay to follow Cdk1 activity and Western blot analysis to assess levels of both cyclin B2 and phosphorylated-tyr-15-Cdk1, how oncogenic Ras suppresses Cdk1 is studied. The results indicate that oncogenic Ras suppresses Cdk1 via induction of persistent phosphorylation of tyr-15-Cdk1. Interestingly, the results reveal that, compared with cyclin B2 in control activated egg extracts, which increased, peaked and then declined during the incubation, oncogenic Ras induced continuous accumulation of cyclin B2. The results also indicate that oncogenic Ras induces continuous accumulation of cyclin B2 primarily through stabilization of cyclin B2, which is mediated by constitutive activation of the Raf-Mek-Erk-p90(rsk) pathway. Taken together, these results indicate that oncogenic Ras suppresses Cdk1 in a complex manner: It induces continuous accumulation of cyclin B2, but also causes persistent inhibitory phosphorylation of tyr-15-Cdk1.
Insights
Oncogenic Ras suppresses Cdk1 activation by maintaining inhibitory phosphorylation and causing continuous cyclin B2 accumulation in Xenopus egg extracts, revealing a complex regulatory mechanism.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cyclin-dependent kinase 1 (Cdk1) activation drives M-phase entry in the cell cycle.
- Cdk1 activation depends on cyclin B synthesis, binding, and removal of inhibitory Tyr15 phosphorylation.
- Oncogenic Ras is known to suppress Cdk1 activation, but the mechanism remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which oncogenic Ras suppresses Cdk1 activation.
- To investigate the effects of oncogenic Ras on cyclin B2 levels and Tyr15-Cdk1 phosphorylation.
Main Methods:
- Utilized Xenopus egg extracts for cell-free experiments.
- Employed histone H1 kinase assays to measure Cdk1 activity.
- Performed Western blot analysis to quantify cyclin B2 and phosphorylated Tyr15-Cdk1 levels.
Main Results:
- Oncogenic Ras induces persistent inhibitory phosphorylation of Tyr15-Cdk1.
- Oncogenic Ras leads to continuous accumulation of cyclin B2, unlike the transient accumulation in controls.
- Cyclin B2 stabilization, mediated by the Raf-Mek-Erk-p90(rsk) pathway, underlies its continuous accumulation.
Conclusions:
- Oncogenic Ras suppresses Cdk1 through a dual mechanism: persistent inhibitory phosphorylation and continuous cyclin B2 accumulation.
- The Raf-Mek-Erk-p90(rsk) pathway is crucial for oncogenic Ras-induced cyclin B2 stabilization.
- This study reveals a complex interplay between oncogenic signaling and cell cycle regulation.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Ras Gene
Ras is a superfamily...
Positive Regulator Molecules
Anaphase Promoting Complex
MAPK Signaling Cascades

